Why the study?
Heart failure of the systemic RV, arrhythmias, heart block, and acquired conditions in ccTGA require complex management, but current evidence on diagnostic, treatment, and management strategies needed synthesis.
Management of heart failure in ccTGA relies heavily on individualized consensus-level decisions due to a scarcity of robust outcome data.
No takes yet. Share an insight, caveat, or question.
Limited HF medication data in ccTGA supports individualized decisions; leaves open need for prospective trials on regimens and timing.
Komori et al. (2025) studied this question.